Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Subchronic safety assessment of CIGB-500 in beagle dog after repeated daily dose administration over 28 days.
Journal: Regulatory toxicology and pharmacology : RTP
Published: October 22, 2024
Tavaborole, a novel boron-containing small molecule for the topical treatment of onychomycosis, is noncarcinogenic in 2-year carcinogenicity studies.
Journal: International journal of toxicology
Published: September 10, 2014
Showing 1-2 of 2
Last Updated: 09/26/2026